Although health hazards associated with cigarette smoking are well-known, the carcinogens that present these hazards have not been quantitatively determined or in some cases qualitatively identified. Dibenzo[a,l]pyrene (DB[a,l]P) has been identified in the biologically active fraction of tobacco smoke condensate. We have recently found this compound to be an extremely potent carcinogen, much stronger than benzo[a]pyrene (BP), suggesting that it may represent a significant risk in cigarette smoke and other environmental pollutants. Therefore, we plan to determine the potency of DB[a,l]P by comparing its tumorigenic activity in rat mammary gland by direct application, and in rat lung by direct application to that of BP, the strongest known environmental polycyclic aromatic hydrocarbon (PAH), and 7,12-dimethylbenz[a]anthracene (DMBA), the strongest known carcinogenic PAH. To provide evidence on the mechanism of carcinogenesis of DB[a,l]P, we propose to investigate 1) whether the metabolite DB[a,l]P 11,12-dihydrodiol is a proximate tumor-initiator; 2) whether DBp[a,l[P activates ras oncogenes similarly to DMBA or BP in mouse skin, rat mammary gland and rat lung tumors by detection of a point mutated Ha-ras, Ki-ras or N-ras gene using amplification by the polymerase chain reaction and direct dideoxyribonucleotide DNA sequencing; 3) the relative reactivity of DB[a,l]P, DB[a,e]P and BP with nucleophiles in one-electron oxidation with Mn(OAc), and in electrochemical oxidation; 4) the binding of DB[a,l]P to DNA in vitro with horseradish peroxidase, prostaglandin H synthase, rat lever microsomes and rat liver nuclei by determining the level of binding and identifying the DNA adducts formed; and 5) the binding of DB[a,l]P in vivo in mouse skin, rat mammary gland and rat lung by determining the level of binding and identifying the DNA adducts formed. With this experimental approach we will assess the carcinogenic potency of DB[a,l]P vs DMBA and BP, and we will also know whether its ability to activate ras oncogenes resembles that of DMBA and BP, and we will also know whether its ability to activate ras oncogenes resembles that of DMBA or BP. Since we expect that the carcinogenicity of DB[a,l]P is similar to that of DMBA, we think our tumorigenicity studies of DB[a,l]P will demonstrate that this PAH represents a significant human health hazard in cigarette smoke and other environmental pollutants. The data obtained from the chemistry, tumorigenicity, DNA-binding studies and oncogene activation will provide significant clues concerning the mechanism of carcinogenesis of DB[a,l]P.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA049917-03
Application #
2093512
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1991-09-30
Project End
1995-08-31
Budget Start
1993-09-01
Budget End
1995-08-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Cavalieri, Ercole L; Rogan, Eleanor G; Li, Kai-Ming et al. (2005) Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]P. Chem Res Toxicol 18:976-83
Saeed, Muhammad; Gunselman, Sandra J; Higginbotham, Sheila et al. (2005) Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3',4'-quinone or enzyme-activated 3'-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens. Steroids 70:37-45
Todorovic, Rosa; Devanesan, Prabu; Rogan, Eleanor et al. (2005) Identification and quantification of stable DNA adducts formed from dibenzo[a,l]pyrene or its metabolites in vitro and in mouse skin and rat mammary gland. Chem Res Toxicol 18:984-90
Saeed, Muhammad; Zahid, Muhammad; Gunselman, Sandra J et al. (2005) Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3',4'-quinone. Implications for mutagenic activity. Steroids 70:29-35
Cavalieri, Ercole L; Rogan, Eleanor G (2004) A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann N Y Acad Sci 1028:247-57
Rogan, Eleanor G; Cavalieri, Ercole L (2004) Estrogen metabolites, conjugates, and DNA adducts: possible biomarkers for risk of breast, prostate, and other human cancers. Adv Clin Chem 38:135-49
Li, Kai-Ming; Todorovic, Rosa; Devanesan, Prabu et al. (2004) Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25:289-97
Cavalieri, Ercole; Rogan, Eleanor; Chakravarti, Dhrubajyoti (2004) The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases. Methods Enzymol 382:293-319
Rogan, Eleanor G; Badawi, Alaa F; Devanesan, Prabu D et al. (2003) Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24:697-702
Mulder, Patrick P J; Devanesan, Prabu; van Alem, Kaj et al. (2003) Fluorobenzo[a]pyrenes as probes of the mechanism of cytochrome P450-catalyzed oxygen transfer in aromatic oxygenations. Free Radic Biol Med 34:734-45

Showing the most recent 10 out of 32 publications